Published in Ann Intern Med on December 01, 1977
Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ (2015) 4.29
Strategies for prevention of osteoporosis and hip fracture. BMJ (1991) 3.78
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60
Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest (1981) 3.15
Race and sex differences in hip fracture incidence. Am J Public Health (1984) 3.07
The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women. Osteoporos Int (2009) 2.77
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01
Calcium supplementation of the diet--II. BMJ (1989) 1.85
Treatment of spinal osteoporosis in postmenopausal women. Br Med J (1980) 1.80
Calcium supplementation of the diet: justified by present evidence. BMJ (1990) 1.53
Calcium supplementation and postmenopausal bone loss. Br Med J (Clin Res Ed) (1984) 1.27
Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br Med J (1980) 1.24
Age-related physiological changes and their clinical significance. West J Med (1981) 1.21
Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut (1993) 1.17
Dietary calcium intake and rates of bone loss in women. J Clin Invest (1987) 1.17
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. Br J Cancer (1990) 1.16
Progesterone and bone: actions promoting bone health in women. J Osteoporos (2010) 0.95
Osteoporosis: an update on pathogenesis and treatment. Can Fam Physician (1983) 0.94
Dietary intake of calcium and postmenopausal bone loss. BMJ (1988) 0.92
The periodic health examination: 2. 1987 update. Canadian Task Force on the Periodic Health Examination. CMAJ (1988) 0.91
In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists. Immunology (1995) 0.91
Hip fracture, skeletal fragility, osteoporosis and hormonal deprivation in elderly women. West J Med (1980) 0.88
Osteoporosis: current concepts. Bull N Y Acad Med (1985) 0.86
A controlled trial of the effect of milk basic protein (MBP) supplementation on bone metabolism in healthy menopausal women. Osteoporos Int (2005) 0.84
A high dietary calcium intake is needed for a positive effect on bone density in Swedish postmenopausal women. Osteoporos Int (1997) 0.80
Risk factors for osteoporosis and associated fractures. Public Health Rep (1990) 0.80
Osteoporosis. Part I. Advanced radiologic assessment using quantitative computed tomography. West J Med (1983) 0.80
Wnt-signaling-mediated antiosteoporotic activity of porcine placenta hydrolysates in ovariectomized rats. Evid Based Complement Alternat Med (2012) 0.79
If preventable why not prevented? West J Med (1980) 0.79
Population screening for osteoporosis to prevent fractures. Qual Health Care (1992) 0.78
Osteoporosis, calcium and physical activity. CMAJ (1987) 0.78
The pathophysiology of bone and joint disease. Am J Pathol (1979) 0.78
Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years. Osteoporos Int (1997) 0.77
Measurement of bone mass by total body calcium: a review. J R Soc Med (1986) 0.77
Understanding osteoporosis. West J Med (1991) 0.76
Identifying postmenopausal patients at risk of significant bone loss. Can Fam Physician (1984) 0.76
Diagnosis and management of involutional osteoporosis. Can Fam Physician (1979) 0.75
Estrogen replacement therapy for postmenopausal osteoporosis. Can Fam Physician (1986) 0.75
Introductory remarks. Public Health Rep (1987) 0.75
Calcium compounds for treating osteoporosis. Can Fam Physician (1984) 0.75
Protection against loss of bone and fracture in postmenopausal women. West J Med (1981) 0.75
Vitamin D deficient states. Pathophysiology and treatment. West J Med (1979) 0.75
The calcium controversy: finding a middle ground between the extremes. Public Health Rep (1990) 0.75
Bioavailability study of calcium sandoz-250 by atomic absorption spectroscopy in albino rats. Ayu (2015) 0.75
Treatment of osteoporosis. Br Med J (1978) 0.75
Risk factors for bone loss in healthy postmenopausal women. Osteoporos Int (1993) 0.75
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
Menopausal changes in calcium balance performance. J Lab Clin Med (1978) 3.47
Bone gain in young adult women. JAMA (1992) 2.73
Calcium absorption and achlorhydria. N Engl J Med (1985) 2.36
Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest (1994) 2.33
Vitamin D and bone health in the elderly. Am J Clin Nutr (1982) 2.21
Calcium balance and calcium requirements in middle-aged women. Am J Clin Nutr (1977) 2.20
Vitamin D: how much do we need, and how much is too much? Osteoporos Int (2000) 2.08
Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int (1998) 2.07
Genetic determination of Colles' fracture and differential bone mass in women with and without Colles' fracture. J Bone Miner Res (2000) 2.07
Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum (1967) 1.98
Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group. Ann Intern Med (2000) 1.94
Pure red blood cell aplasia associated with chlorpropamide therapy. Patient summary and review of the literature. Arch Intern Med (1969) 1.83
Calcium absorption in women: relationships to calcium intake, estrogen status, and age. J Bone Miner Res (1989) 1.82
Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. J Am Diet Assoc (2000) 1.82
Calcium nutrition and bone health in the elderly. Am J Clin Nutr (1982) 1.74
Menopausal changes in bone remodeling. J Lab Clin Med (1978) 1.73
Calcium intake and body weight. J Clin Endocrinol Metab (2000) 1.70
Primary osteoarthrosis of the knee or hip. Prevalence of Heberden nodes in relation to age and sex. JAMA (1975) 1.67
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano) (2000) 1.59
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. J Clin Endocrinol Metab (2000) 1.58
Toward high-throughput genotyping: dynamic and automatic software for manipulating large-scale genotype data using fluorescently labeled dinucleotide markers. Genome Res (2001) 1.58
Periosteal bone formation stimulated by externally induced bending strains. J Bone Miner Res (1994) 1.56
Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab (1971) 1.55
Vitamin D treatment in myelodysplastic syndromes. Br J Haematol (1998) 1.54
A unified concept of osteoporosis. Am J Med (1965) 1.53
Calcium supplementation of the diet: justified by present evidence. BMJ (1990) 1.53
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int (2009) 1.52
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int (2004) 1.48
Bone biomechanical properties in LRP5 mutant mice. Bone (2004) 1.47
Intestinal calcium absorption: concurrent use of oral and intravenous tracers and calculation by the inverse convolution method. J Lab Clin Med (1972) 1.47
Transmenopausal changes in the trabecular bone structure. Bone (2007) 1.46
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. Osteoporos Int (2011) 1.45
Bone response to in vivo mechanical loading in two breeds of mice. Calcif Tissue Int (1998) 1.44
Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group. Arch Intern Med (1991) 1.43
Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res (1996) 1.43
A prospective study of quantitative ultrasound in children and adolescents. J Clin Densitom (2000) 1.41
QTL fine mapping by measuring and testing for Hardy-Weinberg and linkage disequilibrium at a series of linked marker loci in extreme samples of populations. Am J Hum Genet (2000) 1.41
Lead in calcium supplements: cause for alarm or celebration? JAMA (2000) 1.40
Calcium balance during human growth: evidence for threshold behavior. Am J Clin Nutr (1992) 1.40
Bone mass, bone fragility, and the decision to treat. JAMA (1999) 1.40
Medical nutrition therapy for patients with osteoporosis. J Am Diet Assoc (1997) 1.40
Age-related bone loss in women. J Bone Miner Res (1990) 1.39
The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporos Int (1999) 1.38
Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother (2008) 1.37
Vitamin D inadequacy among post-menopausal women: a systematic review. QJM (2005) 1.34
Muscle and bone hypertrophy. Positive effect of running exercise in the rat. Clin Orthop Relat Res (1969) 1.32
Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics (2001) 1.31
A noninvasive, in vivo model for studying strain adaptive bone modeling. Bone (1991) 1.30
Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice. Bone (2001) 1.24
Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab (2000) 1.24
Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J Lab Clin Med (1982) 1.24
Estimation of true calcium absorption. Ann Intern Med (1985) 1.23
Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. Osteoporos Int (2007) 1.21
Protein intake and bone health: the influence of belief systems on the conduct of nutritional science. Am J Clin Nutr (2001) 1.19
Study subjects and ordinary patients. Osteoporos Int (2000) 1.19
Age and weight in osteoarthritis of the hip. Arthritis Rheum (1968) 1.17
Mechanical loading stimulates rapid changes in periosteal gene expression. Calcif Tissue Int (1994) 1.17
A quantitative approach to simple radiographic diagnosis of osteoporosis: its application to the osteoporosis of rheumatoid arthritis. Arthritis Rheum (1967) 1.17
Bone disease in alcohol abuse. Ann Intern Med (1985) 1.16
The syndrome of spinal osteoporosis. Clin Endocrinol Metab (1973) 1.16
Expansion of the medullary cavity at the expense of cortex in postmenopausal osteoporosis. Metab Bone Dis Relat Res (1984) 1.15
The effect of milk supplements on calcium metabolism, bone metabolism and calcium balance. Am J Clin Nutr (1985) 1.14
Skeletal renewal and metabolic bone disease. N Engl J Med (1969) 1.13
Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians. Osteoporos Int (2009) 1.13
Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr (2000) 1.13
Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res (1995) 1.12
Height and weight in symptomatic postmenopausal osteoporosis. Clin Orthop Relat Res (1966) 1.12
Skeletal renewal and metabolic bone disease. N Engl J Med (1969) 1.10
Effect of alcohol on growth, bone density and muscle magnesium in the rat. J Nutr (1965) 1.09
Lessons for nutritional science from vitamin D. Am J Clin Nutr (1999) 1.09
Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15. Mol Psychiatry (2009) 1.09
Hindsight bias among physicians weighing the likelihood of diagnoses. J Appl Psychol (1981) 1.08
Skeletal renewal and metabolic bone disease. N Engl J Med (1969) 1.08
A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects. Bone Miner (1990) 1.08
The impact of lifestyle factors on stress fractures in female Army recruits. Osteoporos Int (2001) 1.07
Osteoporosis-2044. Osteoporos Int (1994) 1.07
Osteoporosis and corticoid drugs. Ann Intern Med (1970) 1.07
Continuous treatment of osteoporosis: current status. Orthop Clin North Am (1981) 1.07
The role of calcium in health and disease. Am J Obstet Gynecol (1999) 1.05
Comparison of surface density and volume of human iliac trabecular bone measured directly and by applied stereology. Calcif Tissue Int (1981) 1.04
Genetic and environmental correlations between obesity phenotypes and age at menarche. Int J Obes (Lond) (2006) 1.03
Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density. Osteoporos Int (2011) 1.03
A survey of haplotype variants at several disease candidate genes: the importance of rare variants for complex diseases. J Med Genet (2005) 1.02
Evaluation and interpretation of calcium-kinetic data in man. Clin Orthop Relat Res (1963) 1.01